Fengxi Su
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Breast Cancer Treatment Studies
- Oncology top 2%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Breast Cancer Treatment Studies 37
- MicroRNA in disease regulation 8
-
- Breast Lesions and Carcinomas 11
- Co-authors
- Erwei Song (34 shared papers)Herui Yao (12 shared papers)Chang Gong (8 shared papers)Qiang Liu (21 shared papers)Fengyan Yu (10 shared papers)Judy Lieberman (2 shared papers)Xiaoqu Hu (2 shared papers)Yijun Huang (1 shared paper)
- Journals
- PLoS ONE (5 papers)Annals of Surgical Oncology (4 papers)Breast Cancer Research and Treatment (3 papers)Annals of Oncology (3 papers)Journal of Cancer Research and Clinical Oncology (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Fengxi Su
83 papers receiving 6.5k citations
Fengxi Su's Hit Papers
Peers
Comparison fields: 5 of 115
- Cancer Research 3k
- Oncology 1.1k
- Molecular Biology 1.3k
- Pathology and Forensic Medicine 314
- Radiology, Nuclear Medicine and Imaging 404
Countries citing papers authored by Fengxi Su
This map shows the geographic impact of Fengxi Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengxi Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengxi Su more than expected).
Fields of papers citing papers by Fengxi Su
This network shows the impact of papers produced by Fengxi Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengxi Su. The network helps show where Fengxi Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Fengxi Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells Hit paper breakdown → | 2007 | 1639 |
| 2 | A Cytoplasmic NF-κB Interacting Long Noncoding RNA Blocks IκB Phosphorylation and Suppresses Breast Cancer Metastasis Hit paper breakdown → | 2015 | 781 |
| 3 | Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells Hit paper breakdown → | 2019 | 623 |
| 4 | Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells Hit paper breakdown → | 2011 | 605 |
| 5 | 2018 | 365 | |
| 6 | Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics–Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer Hit paper breakdown → | 2020 | 234 |
| 7 | Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study Hit paper breakdown → | 2021 | 207 |
| 8 | 2012 | 175 | |
| 9 | 2020 | 143 | |
| 10 | 2016 | 129 | |
| 11 | 2018 | 119 | |
| 12 | 2012 | 116 | |
| 13 | 2017 | 106 | |
| 14 | 2014 | 80 | |
| 15 | 2014 | 78 | |
| 16 | 2014 | 77 | |
| 17 | 2013 | 50 | |
| 18 | 2011 | 47 | |
| 19 | 2016 | 45 | |
| 20 | 2014 | 39 |
About Fengxi Su
Fengxi Su is a scholar working on Cancer Research, Pathology and Forensic Medicine, Oncology, Nutrition and Dietetics and Radiology, Nuclear Medicine and Imaging, having authored 83 papers that have together received 6.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (37 papers), Breast Lesions and Carcinomas (11 papers), MicroRNA in disease regulation (8 papers), Breast Implant and Reconstruction (4 papers), Radiomics and Machine Learning in Medical Imaging (4 papers), Heavy Metal Exposure and Toxicity (3 papers), Cancer Cells and Metastasis (3 papers) and Trace Elements in Health (2 papers). The work is most often cited by research in Cancer Research (3k citations), Oncology (1.1k citations), Molecular Biology (1.3k citations), Pathology and Forensic Medicine (314 citations) and Radiology, Nuclear Medicine and Imaging (404 citations). Fengxi Su has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Erwei Song, Herui Yao, Chang Gong, Qiang Liu, Fengyan Yu, Judy Lieberman, Xiaoqu Hu, Yijun Huang, Qiuhui Pan and Pengcheng Zhu. Their work appears in journals such as PLoS ONE, Annals of Surgical Oncology, Breast Cancer Research and Treatment, Annals of Oncology and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.